MedPath

浙江杭康药业有限公司

Ownership
-
Established
1994-12-03
Employees
-
Market Cap
-
Website
https://www.hacon.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

NMPA:36

Drug Approvals

Hydroxychloroquine Sulfate Tablets

Product Name
硫酸羟氯喹片
Approval Number
国药准字H20249129
Approval Date
Oct 22, 2024
NMPA

Sulfadiazine Silver Cream

Product Name
磺胺嘧啶银乳膏
Approval Number
国药准字H33020325
Approval Date
Mar 14, 2024
NMPA

Compound Amino Acid Lipid Gel

Product Name
万玉苹
Approval Number
国药准字H20060986
Approval Date
Mar 7, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20083942
Approval Date
Oct 22, 2023
NMPA

Zinc Gluconate Chewable Tablets

Product Name
葡萄糖酸锌咀嚼片
Approval Number
国药准字H20083979
Approval Date
Jul 28, 2023
NMPA

Immunoglobulin Ribonucleic Aicd of Hepatitis B for Injection

Product Name
注射用抗乙肝免疫核糖核酸
Approval Number
国药准字H33022305
Approval Date
Jan 19, 2021
NMPA

Tinidazole Capsules

Product Name
替硝唑胶囊
Approval Number
国药准字H10960030
Approval Date
Jan 18, 2021
NMPA

Inosine For Injection

Product Name
注射用肌苷
Approval Number
国药准字H20041475
Approval Date
Dec 24, 2020
NMPA

Inosine For Injection

Product Name
注射用肌苷
Approval Number
国药准字H20041474
Approval Date
Dec 24, 2020
NMPA

Methionine and Vitamin B1 for Injection

Product Name
维力
Approval Number
国药准字H20060712
Approval Date
Dec 24, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.